TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nordic Biomarker AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 86,621 | 95,066 | 80,746 |
Financial expenses | 1,205 | 284 | 294 |
Earnings before taxes | -16,914 | -7 | 9,850 |
EBITDA | -9,659 | 8,723 | 16,729 |
Total assets | 139,058 | 126,397 | 117,433 |
Current assets | 47,454 | 53,227 | 54,125 |
Current liabilities | 47,550 | 26,786 | 21,486 |
Equity capital | 90,407 | 72,136 | 75,753 |
- share capital | 100 | 109 | 111 |
Employees (average) | 75 | 66 | 56 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 65.0% | 57.1% | 64.5% |
Turnover per employee | 1,155 | 1,440 | 1,442 |
Profit as a percentage of turnover | -19.5% | 0.0% | 12.2% |
Return on assets (ROA) | -11.3% | 0.2% | 8.6% |
Current ratio | 99.8% | 198.7% | 251.9% |
Return on equity (ROE) | -18.7% | 0.0% | 13.0% |
Change turnover | |||
Change turnover % | 20% | ||
Chg. No. of employees | |||
Chg. No. of employees % | 18% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.